Preventing Breast Cancer the Focus of 2009-2010 Susan G. Komen

A key challenge in the cancer community today is whether people actually living their own tumors. Susan G. Komen for the Cure ® announced millions of dollars in long-term funding to find out.

Cancer of the world's largest breast in the scientific community is invited to propose long-term funding for research to be - some as large as $ 5000000 - while the role of natural products for human vaccines for the study of breast cancer.

"Prevention is a very hot topic these days, but clear enough scientific evidence to say that this regime, the behavior or the elimination of this agent in the environment reduces the risk of breast cancer does not exist . And we are certainly not a vaccine for breast cancer prevention, "said Mrs. Hala Moddelmog, Komen president and CEO." Because our mission is to end breast cancer forever one, we consider the prevention and the search for a vaccine is critical, and we are willing to invest large sums of money to get those answers. "

The research will be funded solely by the promise of Komen Grants: multi-year, millions of dollars in projects to address important questions of the science of breast cancer today.

Introduced in 2008, Promise Grants require collaboration on a wide range of disciplines - scientists, doctors, nurses, public health experts and lawyers - who often can not work together. These research groups with the greatest potential for the treatment of breast cancer more quickly and provide subsidies for these new promises to find ways to prevent breast cancer.

"And," Do the mission was a breast cancer, which at this point, to treat hundreds of millions of dollars and three decades of research on understanding the disease and developing therapies that involves saving lives to find, "said Diana Rowden, vice president of health sciences." It is absolutely essential that we be prevented by strategies for breast cancer at all, or at least identify the environment and mode of life that may contribute to breast cancer. We know that this research will be closer to us. "

Just $ 450 million in research funding since its inception in 1982, any major development in the treatment of breast cancer in the last 27 years. In the last three years alone, Komen has invested more than $ 230 million in research in the United States and internationally.

The demand for applications
These fairs are held next 3-5 years, with amounts up to $ 5,000,000. Grants for 15 runs in July 2009 will be accepted.

To be eligible for consideration of funding, researchers must demonstrate their prevention approach is useful and should begin testing in humans for the grant expires five years. Grants focus on new strategies for the prevention of breast cancer. The applicant must also describe how the findings of these studies are the first phase of testing more complex and ultimately lead to the prevention of breast cancer.

Research on breast cancer that are most grants are not considered eligible for the Promise 2009-2010, but this assistance, the formulation of the drug using, food and / or behavioral problems or new formulations previously tested methods.

Komen for the Cure, the applications of U.S. and international researchers, but they have to work for charitable organizations. The grant is the involvement of industry partners, can not be reimbursed for expenses or profit.